Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events - A Review on Vorapaxar. Gupta R, Lin M, Mehta A, Aedma SK, Shah R, Ranchal P, Vyas AV, Singh S, Kluck B, Combs WG, Patel NC. Curr Probl Cardiol. 2021 Oct 28:101035. doi: 10.1016/j.cpcardiol.2021.101035. Online ahead of print. PMID: 34718032 Review.